e-learning
resources
Madrid 2019
Monday, 30.09.2019
Hot topics in pulmonary rehabilitation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Short-term effects of supplemental oxygen during exercise in patients with idiopathic pulmonary fibrosis (IPF)
I. Jarosch (Marburg, Germany), T. Schneeberger (Marburg, Germany), R. Gloeckl (Munich, Germany), D. Leitl (Marburg, Germany), C. Schneider (Marburg, Germany), R. Koczulla (Marburg, Germany), K. Kenn (Marburg, Germany)
Source:
International Congress 2019 – Hot topics in pulmonary rehabilitation
Session:
Hot topics in pulmonary rehabilitation
Session type:
Poster Discussion
Number:
3406
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. Jarosch (Marburg, Germany), T. Schneeberger (Marburg, Germany), R. Gloeckl (Munich, Germany), D. Leitl (Marburg, Germany), C. Schneider (Marburg, Germany), R. Koczulla (Marburg, Germany), K. Kenn (Marburg, Germany). Short-term effects of supplemental oxygen during exercise in patients with idiopathic pulmonary fibrosis (IPF). 3406
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
The prevalence of Obstructive Sleep Apnea (OSA) in patients recovering from COVID-19
ERS/ATS joint webinar on rehabilitation after COVID 19 disease: Q&A on Assessment
Related content which might interest you:
Effects of oxygen inhalation during exercise in patients with combined pulmonary fibrosis and emphysema (CPFE)
Source: Annual Congress 2010 - Gas exchange and paediatric exercise testing
Year: 2010
Are there differences in response to pulmonary rehabilitation (PR) in idiopathic pulmonary fibrosis (IPF) and COPD patients?
Source: International Congress 2017 – New insights into pulmonary rehabilitation in patients with chronic lung diseases
Year: 2017
The long-term safety of pirfenidone (PFD) in patients with idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis
Year: 2012
Effect of metformin on clinically relevant outcomes in patients with idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2017 – ILDs: clinical aspects
Year: 2017
Exercise-induced pulmonary hypertension in patients with idiopathic pulmonary fibrosis: effects of oxygen
Source: Eur Respir J 2007; 30: Suppl. 51, 607s
Year: 2007
Protocol for long-term effect of pulmonary rehabilitation under nintedanib in idiopathic pulmonary fibrosis
Source: ERJ Open Res, 7 (3) 00321-2021; 10.1183/23120541.00321-2021
Year: 2021
Patterns of discontinuation in the long-term RECAP study of pirfenidone (PFD) in patients with idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2017 – Idiopathic pulmonary fibrosis (IPF): treatment highlights
Year: 2017
Effects of short-term pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2006; 28: Suppl. 50, 628s
Year: 2006
Time-course changes in pulmonary haemodynamics in patients with idiopathic pulmonary fibrosis (IPF) waiting for lung transplantation (LT)
Source: Eur Respir J 2004; 24: Suppl. 48, 668s
Year: 2004
Benefit of treatment with pirfenidone (PFD) persists over time in patients with idiopathic pulmonary fibrosis (IPF) with limited lung function impairment
Source: International Congress 2016 – IPF treatment I
Year: 2016
Pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis (IPF) with inspiratory muscle training
Source: Annual Congress 2007 - Assessment and outcomes in non-COPD patients
Year: 2007
Determinants of exercise limitation in patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 107s
Year: 2005
Impact of oxygen supplementation on inflammatory response and muscle lesion during high intensity exercise on chronic obstructive pulmonary disease (COPD) patients
Source: Annual Congress 2006 - Muscles, training and rehabilitation
Year: 2006
Effects of oral dual ERA therapy on pulmonary function testing and 6MWT in patients with idiopathic pulmonary fibrosis and pulmonary hypertension
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH and associated PH
Year: 2012
Abnormal pulmonary arterial remodelling in patients with combined pulmonary fibrosis emphysema (CPFE) and idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2011 - Clinical approach of diffuse parenchymal lung disease
Year: 2011
Effect of continued pirfenidone treatment following a ≥ 15% decline in 6-minute walk distance (6MWD) in patients with idiopathic pulmonary fibrosis (IPF): Pooled analysis from 3 pivotal studies
Source: International Congress 2016 – New and old therapies for chronic lung diseases
Year: 2016
Exercise capacity in idiopathic pulmonary fibrosis and COPD
Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis
Year: 2010
Benefits of supplemental oxygen on exercise capacity in IPF patients without exercise-induced hypoxemia
Source: International Congress 2019 – Oxygen supplementation, noninvasive ventilation and mobility aspects of patients with impaired respiration
Year: 2019
Changes in biomarkers in patients with idiopathic pulmonary fibrosis (IPF) treated with nintedanib and sildenafil
Source: International Congress 2019 – The evolving field of idiopathic interstitial pneumonia
Year: 2019
Titrated oxygen requirement and prognostication in idiopathic pulmonary fibrosis
Source: Eur Respir J 2012; 39: 359-365
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept